Global Pharma-Biotech New-Build Report: 727 New Facilities Represent $52 Billion Potential
Global Pharma-Biotech New-Build Report: 727 New Facilities Represent $52 Billion Potential
Attachment: pharmanewbuild
SUGAR LAND--February 28, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical-Biotech Industry has 727 reported facility new builds in the works throughout the globe. Collectively, the sites have generated 855 reported projects, representing a total reported capital investment of $52 billion, which translates to a per-site average of $71.5 million.
Within this article: $125 million medical devices plant in Bloomington, Indiana.
Additional companies: General Motors Corporation (NYSE:GM)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Quebec Digs Up Nearly $17 Billion in 2017 Construction Starts
- Pharma-Biotech Industry Capital Investment Tops $5 Billion for First-Quarte...
- Metals, Chemicals and Pharma Dominate Quebec's First-Quarter 2016 Project K...
- Quebec's $597 Million in Third-Quarter 2015 Project Kickoffs Boosted by Pha...
- General Electric's Third Quarter Not Up to Wall Street Expectations